Establishment Labs Holdings Inc.

NASDAQ:ESTA

Medical - Devices

Healthcare
$70.80 +3.21%

+$2.65 today

Market cap
$2.11B
Beta
1.11
P/E (TTM)
-57.6
EPS (TTM)
-$1.48
52W Low $33.35High $86.00

Volume 0.38M

Average 0.50M

ESTA Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Establishment Labs Holdings Inc.NASDAQ: ESTA

Revenue · Q3 FY2026 · quarter ended Sep 2026

Revenue grows, but more slowly than its trailing trend

Q3 FY2026 revenue of $71.99M rose 33.9% year over year, behind the +38.3% change in trailing-twelve-month revenue. Sequentially, it rose 6.6% from the prior quarter. Over 3 fiscal years it compounded at +9.3% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 7 analysts of $274.8M (+30.2%) for the fiscal year ending Dec 2026, a step up from the +27.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$71.99M+6.6% QoQ
Last fiscal yearDec 2025
$211.08M+27.1% YoY
LTMSep 2026
$264.03M+38.3% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+33.9%+16.6%-17.3 pp
1 year+27.1%+30.2%+3.1 pp
3-year CAGR+9.3%+26.1%+16.8 pp
5-year CAGR+25.3%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
211.08M USD
Year-over-year change
+27.1%
4-year CAGR
+13.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How ESTA compares with its peers on the latest reported figures

  • ESTA's LTM Sep 2026 revenue of $264.03M is the 3rd highest of the 4 companies compared; the peer median is $374.64M.
  • Its year-over-year change of +38.3% is the highest of 4, against a peer median of +1.2%.
  • Over three fiscal years its annual growth of +9.3% compares with a peer median of +1.6%.
ESTA Competitors Peer median
Revenue for ESTA and competitors
Company Period LTM YoY 3-year CAGR
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$1.64B +1.2%+1.6%
INMDInMode Ltd.LTM Mar 2026$374.64M -4.5%-6.6%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$264.03M +38.3%+9.3%
TELATELA Bio, Inc.LTM Jun 2026$79.91M +6.1%+24.7%
Peer median (excluding ESTA) $374.64M+1.2%+1.6%

Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue126.68M161.7M165.15M166.03M211.08M
Cost of Revenue41.28M55.11M58.17M56.5M64.77M
Gross Profit85.4M106.6M106.98M109.53M146.31M
Gross Margin67.4%65.9%64.8%66.0%69.3%
Research & Development18.32M20.27M26.43M19.71M20.25M
Selling, General & Admin92.23M125.98M145.58M139.81M165.07M
Operating Expenses110.54M146.25M172M159.51M185.32M
Depreciation & Amortization4.12M4.34M4.88M7.58M10.47M
EBITDA(26.53M)(56.73M)(58.31M)(56.22M)(22.29M)
EBITDA Margin-20.9%-35.1%-35.3%-33.9%-10.6%
Operating Income(25.14M)(39.66M)(65.03M)(49.99M)(39.01M)
Operating Margin-19.8%-24.5%-39.4%-30.1%-18.5%
Interest Income23K87K1.02M1.48M423K
Interest Expense9.06M11.76M15.39M20.83M25.26M
Other Income / Expenses(14.57M)(33.17M)(13.56M)(34.64M)(19.01M)
Income Before Tax(39.71M)(72.82M)(78.58M)(84.63M)(58.02M)
Pre-Tax Margin-31.3%-45.0%-47.6%-51.0%-27.5%
Income Tax Expense1.43M2.39M(81K)(32K)(6.96M)
Net Income(41.14M)(75.21M)(78.5M)(84.6M)(51.06M)
Net Margin-32.5%-46.5%-47.5%-51.0%-24.2%
EPS (Basic)(1.72)(3.08)(3.07)(3.00)(1.72)
EPS (Diluted)(1.72)(3.08)(3.07)(3.00)(1.72)
Weighted Avg Shares23.97M24.46M25.6M28.16M29.62M
Weighted Avg Shares (Diluted)23.97M24.46M25.6M28.16M29.62M

Establishment Labs Holdings Inc.

NASDAQ:ESTA

Intrinsic Alpha fair value

Locked

Current Price

$70.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.